Rolfe Winkler
Wall Street Journal reporter Rolfe Winkler is now covering health technology.
His new beat comes after a six-month assignment on the newspaper’s health team, where he wrote about topics such as digital contact tracing, vaccine trials, and Palantir’s software to distribute the vaccine. His previous primary focus was venture capital and startups.
Winkler has had a number of scoops on this beat in the past that drove his interest. One was Elon Musk’s Neuralink while another was Outcome Health, about which he led a multi-month investigation, discovered it was misleading customers. Investors sued and the government has already secured three felony guilty pleas and indicted three other executives.
Winkler has been at the Journal since July 2010, first working on the “Heard on the Street” column.
He previously was a columnist for Reuters and also worked as an analyst for a hedge fund.
Financial Times reporter Simon Foy is now covering European banks. He has been covering accounting for the…
Debtwire, the leading provider of global fixed income news, analysis and data for more than…
Amber Kanwar, an anchor for BNN Bloomberg in Canada, is departing at the end of…
Moody's Ratings has promoted Yvette Kantrow to senior vice president and editor in chief. She has been…
Politico reporter Clare Fieseler is leaving the news organization to take on some ocean reporting projects. She…
Wall Street Journal reporter Ben Eisen has signed a contract with Norton to write a book about…